People · Operator
Named in public records as an officer, director or promoter · active 2017–2026 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Promaxo, Inc. | — | Biotechnology | Series C | $60.9M | $414.4M | 2017 |
| Promaxo Holdings, Inc. | — | Biotechnology | Series B | $26.8M | $92.0M | 2026 |
| Neuro42, Inc. | — | Other Health Care | Series B | $22.2M | $96.3M | 2024 |
Amit Vohra at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Amit Vohra on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Derek Hennecke | 2 | 4 |
| Michael Bartholomew | 2 | 2 |
| Dushyant Chipalkatty | 2 | 2 |
| Jonathan Chen | 1 | 3 |
| Abhita Batra | 1 | 2 |
| Dinesh Kumar | 1 | 1 |
| Dan McCormick | 1 | 1 |
| Srirama Venkataraman | 1 | 1 |
| Krishna R. Bhupal | 1 | 1 |
| Rahul R. Talwar | 1 | 1 |
| Shibu R. Gangadharan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.